Skip to main content
. 1997 Mar 4;94(5):2031–2035. doi: 10.1073/pnas.94.5.2031

Table 3.

Amounts of paclitaxel and metabolites excreted by mice with cannulated gall bladder within 90 min after i.v. administration of [3H]paclitaxel

Sample Compound Dose, 10 mg/kg
Dose, 5 mg/kg
Wild type mdr1a(−/−) Wild type mdr1a(−/−)
Plasma (level, ng/ml) Paclitaxel 2020 ± 420 2370 ± 280 289 ± 38 327 ± 44
Bile Paclitaxel 4.81 ± 0.27 2.56 ± 0.58 5.94 ± 1.70 4.10 ± 0.54
3′-p-hydroxypaclitaxel 2.86 ± 0.28 2.48 ± 0.26 4.74 ± 0.69 4.10 ± 0.18
6α-hydroxypaclitaxel 2.00 ± 0.25 1.29 ± 0.24 3.25 ± 0.51 1.98 ± 0.22
3H label 17.9 ± 0.69 15.0 ± 1.5 25.7 ± 4.5 26.6 ± 2.90
Intestinal contents Paclitaxel 10.77 ± 0.25 2.49 ± 0.86* 3.53 ± 0.38 0.98 ± 0.28*
3-p-hydroxypaclitaxel
6α-hydroxypaclitaxel 0.37 ± 0.10 0.37 ± 0.16 0.16 ± 0.05 <0.1
3H label 12.22 ± 0.28 3.79 ± 1.11* 4.63 ± 0.49 1.52 ± 0.05

Excretion is given as percentage of the dose (mean ± SEM; n = 4). ND, Not detectable. 

*

P < 0.05. 

This compound could not be accurately quantified in the intestinal contents due to the presence of an interfering substance.